Jack A. Khattar, President, CEO at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 59,026 shares at $47.23 ($2.8M) on 2025-09-23, disclosed to the SEC on 2025-09-24.
Scheduled sale ($2.8M) by President, CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.23 | 29,513 | $1.4M | 50.0% |
| 2 | $47.23 | 29,513 | $1.4M | 50.0% |
| Total | $47.23 avg | 59,026 | $2.8M | 100% |
| Filing → |
| SUPN | SELL | 2025-10-03 | $183K | — | Filing → |
| SUPN | SELL | 2025-10-02 | $3.9M | — | Filing → |
| SUPN | SELL | 2025-10-01 | $414K | — | Filing → |